ESTIMATED
05/02/2024
05/02/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | $1.95 | $1.95 | $1.95 |
Q2 2024 | 10 | $1.71 | $1.76 | $1.73 |
Q3 2024 | 4 | $1.73 | $1.73 | $1.73 |
Q4 2024 | 4 | $1.79 | $1.79 | $1.79 |
Q1 2025 | 5 | $2.08 | $2.08 | $2.08 |
Q2 2025 | 5 | $1.93 | $1.93 | $1.93 |
Q3 2025 | 5 | $1.95 | $1.95 | $1.95 |
Q4 2025 | 5 | $2.06 | $2.06 | $2.06 |
Q1 2026 | 4 | $2.33 | $2.33 | $2.33 |
Q2 2026 | 4 | $2.16 | $2.16 | $2.16 |
Cardinal Health, Inc. last posted its earnings results on Thursday, May 2nd, 2024. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $1.95 by $0.13. The company had revenue of 54.91 B for the quarter and had revenue of 205.01 B for the year. Cardinal Health, Inc. has generated $1 earnings per share over the last year ($1 diluted earnings per share) and currently has a price-to-earnings ratio of 42.67. Cardinal Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/02/2024 | Q3 2024 | $1.95 | $1.06 | -0.89 | $56.05 B | $54.91 B | 02/01/2024 | Q2 2024 | $1.60 | $1.44 | -0.16 | $57.02 B | $57.45 B | 11/03/2023 | Q1 2024 | $1.40 | $0.02 | -1.38 | $54.76 B | 08/15/2023 | Q4 2023 | $1.48 | -$0.25 | -1.73 | $53.45 B | 05/04/2023 | Q3 2023 | $1.49 | $1.35 | -0.14 | $49.71 B | $50.49 B | 02/02/2023 | Q2 2023 | $1.13 | -$0.50 | -1.63 | $50.72 B | $51.47 B | 11/04/2022 | Q1 2023 | $0.96 | $0.41 | -0.55 | $49.60 B | 08/11/2022 | Q4 2022 | $1.17 | $0.51 | -0.66 | $47.10 B | 05/05/2022 | Q3 2022 | $1.54 | -$5.05 | -6.59 | $44.84 B | 02/03/2022 | Q2 2022 | $1.23 | $0.17 | -1.06 | $45.59 B | $45.46 B | 11/09/2021 | Q1 2022 | $1.32 | $0.94 | -0.38 | $41.84 B | $43.97 B | 08/16/2021 | Q4 2021 | $0.40 | $40.39 B | $42.59 B | 05/06/2021 | Q3 2021 | $1.58 | $0.41 | -1.17 | $39.28 B | 02/05/2021 | Q2 2021 | $1.44 | $2.14 | 0.7 | $41.41 B | $41.54 B | 11/05/2020 | Q1 2021 | $1.14 | -$0.86 | -2 | $38.16 B | $39.07 B | 08/13/2020 | Q4 2020 | $2.25 | $36.85 B | $36.69 B | 05/11/2020 | Q3 2020 | $1.43 | $1.20 | -0.23 | $39.16 B | 02/06/2020 | Q2 2020 | $1.21 | $0.75 | -0.46 | $39.46 B | $39.74 B | 11/07/2019 | Q1 2020 | $1.09 | -$16.63 | -17.72 | $36.73 B | $37.34 B | 08/20/2019 | Q4 2019 | $0.65 | $36.81 B | $37.35 B |
---|
A. Cardinal Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates.
A. In the previous quarter, Cardinal Health, Inc. (NYSE:CAH) reported $2.08 earnings per share (EPS) to beat the analysts' consensus estimate of $1.95 by $0.13.
A. The conference call for Cardinal Health, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Cardinal Health, Inc.'s latest earnings report can be read online.
A. Cardinal Health, Inc. (NYSE:CAH) has a recorded annual revenue of $205.01 B.
A. Cardinal Health, Inc. (NYSE:CAH) has a recorded net income of $205.01 B. Cardinal Health, Inc. has generated $1 earnings per share over the last four quarters.
A. Cardinal Health, Inc. (NYSE:CAH) has a price-to-earnings ratio of 42.67 and price/earnings-to-growth ratio is 4.74.